PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11313422-9	2001	Excess production of PGE(2), TNF-alpha, and IL-10 after DMBA application may be involved in the enhanced local and systemic immunosuppression in DMBA-treated XPA mice.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	145-149	tumor necrosis factor	Mus musculus	29-38	
21670304-3	2011	Using an adoptive transfer strategy and the 7,12-dimethylbenz[alpha]anthracene/terephthalic acid (DMBA/TPA) two-stage model of skin carcinogenesis, we found that both B cells and TNF-alpha are critical for the development of DMBA/TPA-induced papilloma.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	225-229	tumor necrosis factor	Mus musculus	179-188	
21670304-4	2011	Transfer of B cells from DMBA/TPA-treated wild-type mice to Tnf(-/-) mice rescued papilloma development to a wild-type level, a result not observed when B cells from Tnf(-/-) mice were transferred to Rag2(-/-) mice or when TNF-alpha was eliminated selectively in B cells.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	25-29	tumor necrosis factor	Mus musculus	223-232	
21670304-6	2011	These data indicate that during DMBA/TPA-induced squamous carcinogenesis TNF-alpha mediates tumor-promoting activity via regulatory B cells that repress antitumor immunity.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	32-36	tumor necrosis factor	Mus musculus	73-82	
11313422-6	2001	DMBA application induced pronounced production of PGE(2), IL-10, and TNF-alpha in the skin of XPA mice.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	0-4	tumor necrosis factor	Mus musculus	69-78	
10395330-3	1999	TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	122-126	tumor necrosis factor	Mus musculus	0-9	
10395330-3	1999	TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA.	6,11-dimethylbenzo(b)naphtho(2,3-d)thiophene	177-181	tumor necrosis factor	Mus musculus	0-9